Hostname: page-component-7bb8b95d7b-fmk2r Total loading time: 0 Render date: 2024-09-21T19:49:22.719Z Has data issue: false hasContentIssue false
  • English
  • Français

Vaso-active factors in pregnancy

Published online by Cambridge University Press:  10 October 2008

L Myatt
L Myatt*
Affiliation:
University of Cincinnati College of Medicine, Ohio, USA
*
L Myatt, Associate Professor, University of Cincinnati College of Medicine, 231 Bethesda Avenue, Cincinnati, Ohio45267-0526, USA.
Get access Rights & Permissions [Opens in a new window]

Extract

Pregnancy results in profound physiological changes in the cardiovascular system, yet these changes are completely reversible. It is apparent that vaso-active factors, some as yet probably unidentified, which act as humoral or local autocrine or paracrine regulators of vasular resistance, play a major role in these cardio-vascular changes. This role may be heightened in pregnancy when there has to be a large increase in blood flow to the uterus and placenta while maintaining adequate flow to other vascular beds. Our knowledge of the mechanisms of action of these vaso-active factors and their interactions with each other still remains incomplete. Alterations in synthesis and action of these vaso-active factors may occur in pregnancies associated with pregnancy-induced hypertension, pre-eclampsia or intra-uterine growth retardation. Investigation of such alterations may help to elucidate the roles of vaso-active factors in both normal and pathological situations. The gestational hormones oestrogen and progesterone, are obviously prime candidates as overall regulators of the cardiovascular changes of pregnancy and as agents which alter the synthesis or action of other vaso-active factors. Currently, much attention is being focused on the role of local autocrine or paracrine vaso-active factors which may be produced by the endothelium or by the underlying vascular smooth muscle cells and alterations in their production or action in the hyptertensive disorders of pregnancy. The endothelium forms the largest endocrine organ within the body and so its importance in the mediation of vascular events should not be under-estimated. The principal objective of this review is to examine the roles of these many autocrine and paracrine vaso-active factors during pregnancy and their relation with the overall regulation of the vascular system. Changes which may occur and be involved in the aetiology of pre-eclampsia and growth retardation will also be examined.

Type
Articles
Information
Fetal and Maternal Medicine Review , Volume 4 , Issue 1 , January 1992 , pp. 15 - 36
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Goodlin, RC, Quaife, MA, Dirkson, JW. The significance diagnosis and treatment of maternal hypovolemia as associated with fetal/maternal illness. Semin Perinatol 1981; 5: 163–74.Google ScholarPubMed
2Gant, NF, Daley, GL, Chand, S, Whalley, PJ, Macdonald, PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973; 52: 2682–89.CrossRefGoogle ScholarPubMed
3Chesley, LC, Valenti, C. The evaluation of tests to differentiate pre-eclampsia from hypertensive disease. Am J Obstet Gynecol. 1958; 75: 1165–73.CrossRefGoogle ScholarPubMed
4Zuspan, FP, Nelson, GH, Ahlquist, RP. Epinephrine infusions in normal and toxemic pregnancy. I: Nonesterified fatty acids and cardiovascular alterations. Am J Obstet Gynecol. 1964; 90: 88–98.CrossRefGoogle ScholarPubMed
5Talledo, OE, Chesley, LC, Zuspan, FP. Renin angiotensin system in normal and toxemic pregnancies. III: Differential sensitivity to angiotensin II and norepinephrine in toxemia of pregnancy. Am J Obstet Gynecol. 1968; 100: 218–21.CrossRefGoogle Scholar
6Paller, MS. Mechanism of decreased pressor responsiveness to ANG II, NE and vasopressin in pregnant rats. Am J Physiol. 1984; 247: H100–108.Google ScholarPubMed
7Conrad, KP, Colpoys, MC. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. J Clin Invest 1986; 77: 230–45.CrossRefGoogle ScholarPubMed
8Goodman, RP, Killam, AP, Brash, AR, Branch, RA. Prostacyclin production during pregnancy: a comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol 1982; 142: 817–22.CrossRefGoogle ScholarPubMed
9Myatt, L, Brewer, A, Prada, J. Nitric oxide production in normotensive pregnancy: measurement of urinary nitrate. 39th Annual Meeting of the Society for Gynecologic Investigation, 1992; Abstract no. 93.Google Scholar
10Mackey, K, Meyer, MC, Skrewalt, WS, Starcher, BC, McLaughlin, MK. Composition and mechanics of mesenteric resistance arteries from pregnant rats. Am J Physiol 1992 (in press).Google ScholarPubMed
11Novak, K, Kaufman, S. Effect of pregnancy, estradiol and progesterone on pressor responsiveness to angiotensin II. Am J Physiol 1991; 261: R1164–70.Google ScholarPubMed
12Killam, AP, Rosenfeld, CR, Battaglia, FC, Makowski, EL, Meschia, G. Effect of estrogens on the uterine blood flow of oophorectomized ewes. Am J Obstet Gynecol 1973; 115: 1045–57.CrossRefGoogle ScholarPubMed
13Greiss, FC Jr, Rose, JC. Vascular physiology of the nonpregnant uterus. In: Wynn, RM, Jollie, WP eds. Biology of the uterus. New York: Plenum Press, 1989: 69–87.CrossRefGoogle Scholar
14Van Buren, GA, Yang, DS, Siddiqi, T, Clark, KE. Endothelium-derived relaxing factor mediates estrogen-induced increases in uterine blood flow. 12th Annual Meeting of the Society for Perinatal Obstetricians, 1992: Abstract no. 42.Google Scholar
15Weir, RJ, Brown, JJ, Fraser, R. Relationship between plasma renin, renin-substrate, angiotensin II, aldosterone and electrolytes in normal pregnancy. J Clin Endocrinol Metab 1975; 40: 108–15.CrossRefGoogle Scholar
16Miyamori, I, Fitzgerald, GA, Brown, HJ. Prostacyclin stimulates the renin angiotensin aldosterone systems in man. J Clin Endocrinol Metab 1979; 49: 943–44.CrossRefGoogle ScholarPubMed
17Lenz, T, James, GD, Laragh, JH, Sealey, JE. Prorenin secretion from human placenta perfused in vitro. Am J Physiol 1991; 260: E876–82.Google ScholarPubMed
18Brown, GP, Venuto, RC. Angiotensin II receptor alternations during pregnancy in rabbits. Am J Physiol 1986; 251: E58–64.Google Scholar
19Everett, RB, Worley, RJ, MacDonald, PC, Gant, NF. Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. J Clin Endocrinol Metab 1978; 46: 1007–10.CrossRefGoogle ScholarPubMed
20Broughton Pipkin, F, Hunter, JC, Turner, SR, O’Brien, PMS. Prostaglandin E2 attenuates the pressor response to angiotensin II in pregnant but not non-pregnant humans. Am J Obstet Gynecol 1982; 142: 168–76.CrossRefGoogle ScholarPubMed
21Broughton, Pipkin F, Morrison, R, O’Brien, PMS. Effects of prostacyclin on the pressor response to angiotensin II in human pregnancy. European J Clin Invest 1984; 14: 3.Google Scholar
22Hines, T, Porter, JP. Role for central angiotensin II in control of blood pressure during pregnancy. Am J Physiol 1989; 257: R1457–61.Google ScholarPubMed
23Magness, RR, Osei-Boaten, K, Mitchell, MD, Rosenfeld, CR. In vitro prostacyclin production by ovine uterine and systemic arteries: effects of angiotensin II. J Clin Invest 1985; 76: 2206–12.CrossRefGoogle ScholarPubMed
24Glance, DG, Elder, MG, Myatt, L. Prostaglandin production and stimulation by angiotensin II in the isolated perfused human placental cotyledon. Am J Obstet Gynecol 1985; 151: 387–91.CrossRefGoogle ScholarPubMed
25Naden, RP, Rosenfeld, CR. The effect of angiotensin II on uterine systemic vasculatures in pregnant sheep. J Clin Invest 1981; 68: 468–74.CrossRefGoogle ScholarPubMed
26Kilbom, A, Wennmalm, A. Endogenous prostaglandins as local regulators of blood flow in man. Effect of indomethacin on reactive and functional hyperaemia. J Physiol 1976; 257: 109–21.CrossRefGoogle ScholarPubMed
27Szczeklik, A, Gryglewski, RJ, Nizankowska, R, Musial, J, Picton, R, Mruk, J. Circulatory and antiplatelet effects of intravenous prostacyclin in healthy man. Pharmacol Res Commun 1978; 10: 545–56.CrossRefGoogle Scholar
28Sun, FF, Taylor, BM. Metabolism of prostacyclin in rat. Biochemistry 1978; 17: 4096–101.CrossRefGoogle ScholarPubMed
29Bedwani, JR, Marley, PB. Enhanced inactivation of prostaglandin E2 by the rabbit lung during pregnancy or progesterone treatment. Br J Pharmacol 1975; 53: 547–54.CrossRefGoogle ScholarPubMed
30Blair, IA, Barron, SE, Waddell, KA, Lewis, PT, Dollery, CT. Prostacyclin is not a circulating hormone in man. Prostaglandins 1982; 23: 579–89.CrossRefGoogle Scholar
31Mullane, KM, Moncada, S. Prostacyclin release and the modulation of some vasoactive hormones. Prostaglandins 1980; 20: 25–49.CrossRefGoogle ScholarPubMed
32Negus, P, Tannen, RL, Dunn, MJ. Indomethacin potentiates the vasoconstrictor actions of angiotensin II in normal man. Prostaglandins 1987; 12: 175–80.CrossRefGoogle Scholar
33Glance, DG, Elder, MG, Myatt, L. The actions of prostaglandins and their interactions with angiotensin II in the isolated perfused human placental cotyledon. Br J Obstet Gynaecol 1986; 93: 488–94.CrossRefGoogle ScholarPubMed
34Fitzgerald, DJ, Mayo, G, Catella, F, Entman, SS, Fitzgerald, GA. Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. Am J Obstet Gynecol 1987; 157: 325–30.CrossRefGoogle ScholarPubMed
35Catella, F, Lawson, JA, Fitzgerald, DJ, Fitzgerald, GA. Endogenous biosynthesis of arachidonic epoxides in humans: increased formation in pregnancy-induced hypertension. Proc Natl Acad Sci USA 1990; 87: 5893–97.CrossRefGoogle ScholarPubMed
36Jogee, M, Myatt, L, Elder, MG. Decreased prostacyclin production by placental cells in culture from pregnancies complicated by fetal growth retardation. Br J Obstet Gynaecol 1982; 89: 849–52.Google Scholar
37Remuzzi, G, Marchesi, D, Zoja, C et al. Reduced umbilical and placental prostacyclin in severe pre-eclampsia. Prostaglandins 1980; 20: 105–10.CrossRefGoogle ScholarPubMed
38Stuart, MJ, Clark, DA, Sunderzi, SG et al. Decreased prostacyclin production: a characteristic of chronic placental insufficiency syndrome. Lancet 1981; i: 1126–28.CrossRefGoogle Scholar
39Bussolino, F, Benedetto, C, Massorbrio, M, Camussi, G. Maternal and vascular prostacyclin activity in pre-eclampsia. Lancet 1980; ii: 702.CrossRefGoogle Scholar
40Fitzgerald, DJ, Entman, SS, Mulloy, K, Fitzgerald, GA. Decreased prostacyclin biosynthesis preceding the clinical manifestations of pregnancy-induced hypertension. Circulation. 1987; 75: 956–63.CrossRefGoogle ScholarPubMed
41Fitzgerald, DJ, Rocki, W, Murray, R, Mayo, G, Fitzgerald, CA. Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 1990; i: 751–54.CrossRefGoogle Scholar
42Remuzzi, G, Zoja, C, Marchesi, D et al. Plasmatic regulation of vascular prostacyclin in pregnancy. Br Med J 1981; 282: 512–14.CrossRefGoogle ScholarPubMed
43Maseki, M, Nishigaki, I, Hagihara, M, Tomoda, Y, Yagi, K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnancy subjects with or without pre-eclampsia. Clin Chim Acta 1981; 115: 155–61.Google ScholarPubMed
44Wickens, D, Wilkins, MH, Lunec, J, Ball, G, Dormandy, TL. Free-radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancy. Ann Clin Biochem 1981; 18: 158–62.CrossRefGoogle ScholarPubMed
45Roberts, JM, Taylor, RN, Musci, TJ, Rodgers, GM, Hubel, CA, McLaughlin, MK. Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–204.CrossRefGoogle ScholarPubMed
46Hubel, CA, Roberts, JM, Taylor, RN, Musci, TJ, Rogers, GM, McLaughlin, MK. Lipid peroxidation in pregnancy: new perspectives on pre-eclampsia. Am J Obstet Gynecol 1989; 161: 1025–34.CrossRefGoogle Scholar
47Worley, RJ. Pathophysiology of pregnancy-induced hypertension. Clin Obstet Gynecol 1984; 27: 821–35.CrossRefGoogle ScholarPubMed
48O’Brien, PMS, Morrison, R, Pipkin, Broughton F. The effect of dietary supplementation with linoleic and gammalinolenic acids on the pressor response to angiotensin II - a possible role in pregnancy-induced hypertension?. Br J Clin Pharmacol 1984; 19: 335–42.CrossRefGoogle Scholar
49Fidler, J, Bennett, MJ, de Swiet, M, Ellis, C, Lewis, PJ. Treatment of pregnancy-induced hypertension with prostacyclin. Lancet 1980; ii: 31–32.CrossRefGoogle Scholar
50Belch, JJF, Thorburn, J, Greer, IA, Sarfo, S, Prentice, CRM. Intravenous prostacyclin in the management of pregnancies complicated by severe hypertension. Clin Exp Hypertens 1984; B4: 75–86.Google Scholar
51Husslein, P, Gitsch, E, Pateisky, N, Philipp, K, Leodolter, S, Sinzinger, H. Prostacyclin does not influence placental blood pool in vivo. Gynecol Obstet Invest 1984; 19: 78–81.CrossRefGoogle Scholar
52Crandon, AJ, Isherwood, DM. Effect of aspirin on incidence of pre-eclampsia. Lancet 1979; i: 1356.CrossRefGoogle Scholar
53Beaufils, M, Uzan, S, Donsimoni, R, Colan, JC. Prevention of pre-eclampsia by early anti-platelet therapy. Lancet 1985; i: 840–42.CrossRefGoogle Scholar
54Wallenburg, HCS, Dekker, GA, Makowitz, JW, Rotmans, P. Low-dose aspirin prevents pregnancy induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; i: 1–3.CrossRefGoogle Scholar
55Wallenburg, HCS, Rotmans, N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987; 157: 1230–35.CrossRefGoogle ScholarPubMed
56Benigni, A, Gregorini, A, Frusca, T et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321: 357–62.CrossRefGoogle ScholarPubMed
57Trudinger, BJ, Cook, CM, Thompson, RS, Giles, WB, Connelly, A. Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency. Am J Obstet Gynecol 1988; 159: 681–85.CrossRefGoogle ScholarPubMed
58Schiff, E, Peleg, E, Goldenberg, M et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high-risk pregnancies. N Engl J Med 1989; 321: 351–56.CrossRefGoogle ScholarPubMed
59McParland, P, Pearce, JM, Chamberlain, GVP. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 1990; 335: 1552–55.CrossRefGoogle ScholarPubMed
60Imperiale, TF, Petrulis, AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991; 266: 261–65.Google ScholarPubMed
61Uzan, S, Beaufils, M, Breart, G, Bazin, B, Capitant, C, Paris, J. Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. Lancet 1991; 337: 1427–31.CrossRefGoogle ScholarPubMed
62Schiff, E, Barkai, G, Ben-Baruch, G, Mashiach, S. Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension. Obstet Gynecol 1990; 76: 742–44.CrossRefGoogle Scholar
63Spitz, B, Magness, RR, Cox, SM, Brown, CEL, Rosenfeld, CR, Gant, NF. Low-dose aspirin. I: effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II. Am J Obstet Gynecol 1988; 159: 1035–43.CrossRefGoogle ScholarPubMed
64Brown, CEL, Gant, NF, Cox, K, Spitz, B, Rosenfeld, CR, Magness, RR. Low-dose aspirin. II: Relationship of angiotensin II pressor responses, circulating eicosanoids and pregnancy outcome. Am J Obstet Gynecol 1990; 163: 1853–61.CrossRefGoogle ScholarPubMed
65Wallenburg, HC, Dekker, GA, Makowitz, JW, Rotmans, N. Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women. Am J Obstet Gynecol 1991; 164: 1169–73.CrossRefGoogle ScholarPubMed
66Van Assche, FA, Spitz, B, Vermylen, J, Deckmijn, H. Preliminary observations on treatment of pregnancy-induced hypertension with a thromboxane synthetase inhibitor. Am J Obstet Gynecol 1984; 148: 216–18.CrossRefGoogle ScholarPubMed
67Van Assche, FA, Spitz, B. Thromboxane synthetase inhibition in pregnancy-induced hypertension. Am J Obstet Gynecol 1988; 159: 1015–16.CrossRefGoogle ScholarPubMed
68Keith, JC, Miller, K, Eggleston, MIC et al. Effects of thromboxane synthetase inhibition on maternal fetal homeostasis in gravid ewes with ovine pregnancy-induced hypertension. Am J Obstet Gynecol 1989; 161: 1305–13.CrossRefGoogle ScholarPubMed
69Cardin, JP, Ross, MG, Gore Ervin, M et al. Fetal and maternal responses to intravenous infusion of a thromboxane synthetase inhibitor. Am J Obstet Gynecol 1990; 163: 1345–49.CrossRefGoogle ScholarPubMed
70Furchgott, RF, Zawadski, JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–76.CrossRefGoogle ScholarPubMed
71Furchgott, RF, Vanhoutte, PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3: 2007–18.CrossRefGoogle ScholarPubMed
72Gruetter, CA, Barry, BK, McNamara, DB, Gruetter, DY, Kadowitz, PJ, Ignarro, LJ. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosamine. J Cyclic Nucleotide Protein Phosphor Res 1979; 5: 211–14.Google Scholar
73Ignarro, LJ, Lippton, J, Edwards, JC et al. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide. Evidence for the involvement of s-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1989; 218: 739–49.Google Scholar
74Palmer, RMJ, Ashton, DS, Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664–66.CrossRefGoogle ScholarPubMed
75Schini, VB, Vanhoutte, PM. L-arginine evokes both endothelin dependent and independent relaxations in L-arginine depleted aortas of the rat. Circ Res 1991; 68: 209–10.CrossRefGoogle Scholar
76Bredt, DS, Synder, SH. Isolation of nitric oxide synthetase, a calmodulin requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682–85.CrossRefGoogle ScholarPubMed
77Curran, RD, Billiar, TR, Stuehr, DJ, Hofmann, K, Simmons, RL. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989; 170: 1769–74.CrossRefGoogle ScholarPubMed
78Marletta, MA, Yoon, PS, Iyengar, R, Leaf, CD, Wishnok, JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706–11.CrossRefGoogle ScholarPubMed
79Radomski, MW, Palmer, RMJ, Moncada, S. Characterization of the L-arginine nitric oxide pathway in human platelets. Br J Pharmacol 1990; 101: 325–28.CrossRefGoogle ScholarPubMed
80Palmer, RMJ, Moncada, S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 1989; 49: 348–52.CrossRefGoogle Scholar
81Lambert, LE, Whitten, JP, Barron, BM, Cheng, HC, Doherty, NS, McDonald, IA. Nitric oxide synthesis in the CNS, endothelin and macrophage differs in its sensitivity to inhibition by arginine analogs. Life Sci 1991; 48: 67–75.CrossRefGoogle Scholar
82Rees, DD, Palmer, RMJ, Moncada, S. Role of endothelium derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375–78.CrossRefGoogle ScholarPubMed
83Gardiner, SM, Compton, AM, Bennett, T et al. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 1990; 15: 486–92.CrossRefGoogle ScholarPubMed
84Vallance, P, Collier, J, Moncada, S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997–1000.CrossRefGoogle ScholarPubMed
85Vallance, P, Collier, J, Moncada, S. Nitric oxide synthesized from L-arginine mediates endothelium-dependent dilatation in human veins. Cardiovasc Res 1989; 23: 1053–57.CrossRefGoogle ScholarPubMed
86Radomski, MW, Palmer, RMJ, Moncada, S. An L-arginine: nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193–97.CrossRefGoogle ScholarPubMed
87Radomski, MW, Palmer, RMJ, Moncada, S. The anti-aggregating properties of vascular endothelium. Interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639–46.CrossRefGoogle ScholarPubMed
88De Nucci, G, Gryglewski, RJ, Warner, TD et al. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA 1988; 85: 2334–38.CrossRefGoogle ScholarPubMed
89Nelson, SH, Suresh, MS. Comparison of nitroprusside and nonpregnant patients. Anesthesiology 1988; 68: 541–47.CrossRefGoogle ScholarPubMed
90Greiss, FC Jr, Gobble, FL Jr, Anderson, SG et al. Effect of acetylcholine on the uterine vascular bed. Am J Obstet Gynecol 1967; 99: 1073–77.CrossRefGoogle ScholarPubMed
91Resnik, R, Killam, AP, Barton, MD et al. The effect of various vaso-active compounds upon the uterine vascular bed. Am J Obstet Gynecol 1967; 125: 201–206.CrossRefGoogle Scholar
92Bell, C. Dual vasoconstrictor and vasodilator innervation of the uterine arterial supply in the guinea pig. Circ Res 1968; 23: 279–89.CrossRefGoogle ScholarPubMed
93Weiner, C, Martinez, E, Zhu, LK et al. In vitro release of endothelium-derived relaxing factor by acetylcholine is increased during the guinea pig pregnancy. Am J Obstet Gynecol 1989; 161: 1599–605.CrossRefGoogle ScholarPubMed
94Osol, G, Knutson, S. Endothelial and smooth muscle cell reactivity of resistance-sized arteries from the uteroplacental circulation. 36th Annual Meeting of Society for Gynecologic Investigation, 1989; Abstract no. 275.Google Scholar
95Weiner, C, Zhu, L, Chestnut, D et al. Effect of pregnancy upon endothelial modulation of norepinephrine constriction. 37th Annual Meeting of Society for Gynecologic Investigation, 1990; Abstract no 185.Google Scholar
96Umans, JG, Lindheimer, MD, Barron, WM. Pressor effects of endothelium-derived relaxing factor inhibition in conscious virgin and gravid rats. Am J Physiol 1990; 259: F293–96.Google ScholarPubMed
97Ahokas, RA, Sibai, BM, Effect of endothelium-dependent relaxing factor (EDRF) inhibition on angiotensin II (AII) pressor responses in pregnant and nonpregnant rats. 38th Annual Meeting Society for Gynecologic Investigation, 1991: Abstract no. 201.Google Scholar
98Ahokas, RA, Mercer, BM, Sibai, BM. Enhanced endothelium-derived relaxing factor activity in pregnant spontaneously hypertensive rats. Am J Obstet Gynecol 1991; 165: 801–807.CrossRefGoogle ScholarPubMed
99Conrad, KP, Vernier, KA. Plasma level, urinary excretion and metabolic production of cGMP during gestation in rats. Am J Physiol 1989; 257: (Regulatory Integrative Comp Physiol 26): R847–53.Google ScholarPubMed
100Green, LC, De Luzuriaga, KR, Wagner, DA et al. Nitrate biosynthesis in man. Proc Natl Acad Sci USA 1981; 78: 7764–68.CrossRefGoogle ScholarPubMed
101Leaf, CD, Wishnok, JS, Tannenbaum, SR. L-arginine is a precursor for nitrate biosynthesis in man. Biochem Biophys Res Commun 1989; 163: 1032–37.CrossRefGoogle Scholar
102Gryglewski, RJ, Botting, RM, Vane, JR. Mediators produced by the endothelial cell. Hypertension 1988; 12: 530–48.CrossRefGoogle ScholarPubMed
103Panza, JA, Quyyumi, AA, Brush, JE et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–27.CrossRefGoogle ScholarPubMed
104Ludmer, PL, Selwyn, AP, Shook, PL. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046–51.CrossRefGoogle ScholarPubMed
105Kamata, K, Miyata, N, Kasuya, Y. Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozocin-induced diabetic rats. Br J Pharmacol 1989; 97: 614–18.CrossRefGoogle Scholar
106Pinto, A, Sorrentino, R, Sorrentino, P et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 164: 507–13.CrossRefGoogle ScholarPubMed
107Myatt, L, Brewer, A, Brockman, DE. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 1991; 164: 687–92.CrossRefGoogle ScholarPubMed
108Myatt, L, Brewer, AS, Langdon, G, Brockman, DE. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol 1991; 165: 1717–22.CrossRefGoogle Scholar
109Myatt, L, Langdon, G, Brewer, A, Brockman, DE. Characterization of nitric oxide synthase in the human placental villous vascular tree. 39th Annual Meeting Society for Gynecologic Investigation, 1992: Abstract no. 64.Google Scholar
110Garg, UC, Hassid, A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774–77.CrossRefGoogle ScholarPubMed
111Sarrel, PM, Lindsay, DC, Poole-Wilson, PA, Collins, P. Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet 1990; 336: 1030–32.CrossRefGoogle ScholarPubMed
112Inoue, A, Yanagisawa, M, Kumura, S et al. The human endothelin family. Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989; 86: 2863–67.CrossRefGoogle ScholarPubMed
113Yanagisawa, M, Kurihara, H, Kumura, S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–15.CrossRefGoogle ScholarPubMed
114Milner, P, Bodin, P, Loesch, A et al. Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun 1990; 170: 649–56.CrossRefGoogle ScholarPubMed
115Miller, VM, Kamori, K, Burnett, JC Jr, Vanhoutte, PM. Differential sensitivity to endothelin in canine arteries and veins. Am J Physiol 1989; 257: H1127–31.Google ScholarPubMed
116Cernacek, P, Stewart, DJ. Immunoreactive endothelin in human plasma. Marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun 1989; 161: 562–67.CrossRefGoogle ScholarPubMed
117Consigny, PM. Endothelin-1 increased arterial sensitivity to 5-hydroxytryptamine. Eur J Pharmacol 1990; 186: 239–45.CrossRefGoogle ScholarPubMed
118Yang, Z, Richard, V, van Segesser, L et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm. Circulation 1990; 82: 188–95.CrossRefGoogle ScholarPubMed
119Benigni, A, Gaspari, F, Orisio, S et al. Human placenta expresses endothelin gene and corresponding protein is excreted in urine in increasing amounts during normal pregnancy. Am J Obstet Gynecol 1991; 164: 844–48.CrossRefGoogle ScholarPubMed
120Taylor, RN, Varma, M, Teng, NNH, Roberts, JM. Women with pre-eclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990; 71: 1675–77.CrossRefGoogle ScholarPubMed
121Nova, A, Sibai, BM, Barton, JR, Mercer, BM, Mitchell, MD. Maternal plasma level of endothelin is increased in pre-eclampsia. Am J Obstet Gynecol 1991; 165: 724–27.CrossRefGoogle Scholar
122Molnar, M, Hertelendy, F. Pressor responsiveness to endothelin is not attenuated in gravid rats. Life Sci 1990; 47: 1463–68.CrossRefGoogle Scholar
123Aran, H, Hori, S, Aramori, I, Ohkubo, H, Nakanishi, S. Cloning and expression of a cDNA encoding for endothelin receptor. Nature 1990; 348: 730–32.Google Scholar
124Sakurai, T, Yanagisawa, M, Takuwa, Y et al. Cloning of a cDNA encoding a nonisopeptide-selective subtype of the endothelin receptor. Nature 1990; 348: 732–35.CrossRefGoogle ScholarPubMed
125Kozuka, M, Ito, T, Hirose, S, Takahashi, K, Hagiwara, H. Endothelin induces two types of contractions of rat uterus: phasic contractions by way of voltage-dependent calcium channels and developing contractions through a second type of calcium channel. Biochem Biophys Res Commun 1989; 159: 317–23.CrossRefGoogle Scholar
126Davenport, AP, Nunez, DJ, Hall, JA et al. Autoradiographical localization of binding sites for porcine [125I]endothelin-1 in humans, pigs, and rats. Functional relevance in humans. J Cardiovasc Pharmacol 1989; 13: S166–70.CrossRefGoogle ScholarPubMed
127Onda, H, Ohkubo, S, Ogi, K et al. One of the endothelin gene family, endothelin 3 gene, is expressed in the placenta. FEBS Lett 1990; 261: 327–30.CrossRefGoogle ScholarPubMed
128Fischli, W, Clozel, M, Guilly, C. Specific receptors for endothelin on membranes from human placenta characterization and use in a binding assay. Life Sci 1989; 44: 1429–36.CrossRefGoogle ScholarPubMed
129Robaut, C, Mondon, F, Bandet, J, Ferre, F, Cavero, I. Regional distribution and pharmacological characterization of [125I] endothelin-1 binding sites in human fetal placental vessels. Placenta 1991; 12: 55–67.CrossRefGoogle ScholarPubMed
130Komuro, I, Kurihara, H, Sugiyama, T et al. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988; 238: 249–52.CrossRefGoogle ScholarPubMed
131Forkes, GB. Calcium accumulation by the human fetus. Pediatrics 1976; 57: 976–77.Google Scholar
132Schofield, C, Stewart, J, Wheeler, E. The diets of pregnant and nonpregnant women in different social groups in London and Edinburgh: calcium, iron, retinol, ascorbic acid and folic acid. Br J Nutr 1989; 62: 363–77.CrossRefGoogle Scholar
133Duggin, GG, Lyneham, RC, Dale, NE, Evans, RA, Tiller, DJ. Calcium balance in pregnancy. Lancet 1974; ii: 926–27.CrossRefGoogle Scholar
134Kumar, R, Cohen, WR, Silva, P, Epstein, FH. Elevated 1, 25 (OH)2D3 plasma levels in normal human pregnancy and lactation. J Clin Invest 1979; 64: 342.CrossRefGoogle Scholar
135Heaney, RP, Skillman, TG. Calcium metabolism in normal human pregnancy. J Clin Endocrinol Metab 1971; 36: 661–70.CrossRefGoogle Scholar
136Pitkin, RM. Calcium metabolism in pregnancy and the perinatal period: a review. Am J Obstet Gynecol 1985; 151: 99–109.CrossRefGoogle ScholarPubMed
137Davis, OK, Hawkins, DS, Rubin, LP, Posillico, JP, Brown, EM, Schiff, I. Serum parathyroid hormone (PTH) in pregnant women determined by an immunoradiometric assay for intact PTH. J Clin Endocrinol Metab 1988; 67: 850–52.CrossRefGoogle ScholarPubMed
138McCarron, DA. Low serum concentrations of ionized calcium in patients with hypertension. N Engl J Med 1982; 307: 226–28.CrossRefGoogle ScholarPubMed
139Resnick, LM. Uniformity and diversity of calcium metabolism in hypertension. A conceptual framework. Am J Med 1987; 82: (suppl IB): 16–25.CrossRefGoogle ScholarPubMed
140Belizan, JM, Villar, J, Pineda, O. Reduction of blood pressure with calcium supplementation in young adults. JAMA 1983; 259: 1161–65.CrossRefGoogle Scholar
141Lyle, RM, Melby, CH, Hyner, GC. Metabolic differences between subjects whose blood pressure did or did not respond to oral calcium supplementation. Am J Clin Nutr 1987; 47: 1030–35.CrossRefGoogle Scholar
142Grobbee, DE, Hofman, A. Effect of calcium supplementation on diastolic blood pressure in young people with mild hypertension. Lancet 1986; ii: 703–707.CrossRefGoogle Scholar
143Resnick, LM, Nicholson, JP, Laragh, JH. Calcium metabolism in essential hypertension: relationship to altered renin system activity. Fed Proc 1987; 45: 2739–45.Google Scholar
144Osofsky, HJ. Relationship between prenatal medical and nutritional measures, pregnancy outcome and early infant development in an urban poverty setting. Am J Obstet Gynecol 1975; 123: 682–90.CrossRefGoogle Scholar
145Belizan, JM, Villar, J. The relationship between calcium intake and edema proteinuria and hypertension gestosis: an hypothesis. Am J Clin Nutr 1980; 33: 2202–10.CrossRefGoogle Scholar
146Hatton, DC, Scrogin, KE, Metz, JA, McCarron, DA. Dietary calcium alters blood pressure reactivity in spontaneously hypertensive rat. Hypertension 1989; 13: 622–29.CrossRefGoogle Scholar
147Belizan, JM, Pineda, O, Sainz, E, Meneridez, LA, Villar, J. Rise of blood pressure in calcium-deprived pregnant rats. Am J Obstet Gynecol 1981; 141: 163–69.CrossRefGoogle ScholarPubMed
148Prada, J, Ross, R, Clark, K. Hypertensive effects of starvation: role of Ca2+ in the pregnant sheep. 34th Annual Meeting of the Society for Gynecologic Investigation, 1987: Abstract no. 62P.Google Scholar
149Prada, J, Brockman, D, Moore, K, Clark, K. Hypocalcemia leads to pregnancy-induced hypertension in sheep. 35th Annual Meeting of the Society for Gynecologic Investigation, 1988: Abstract no. 7.Google Scholar
150Richards, SR, Nelson, MD, Zuspan, FP. Calcium levels in normal and hypertensive pregnant patients. Am J Obstet Gynecol 1984; 149: 168–71.CrossRefGoogle ScholarPubMed
151Moodley, J, Rampersadh, S, Becker, P, Norman, RT, O’Dondl, D. Serum calcium ion concentrations in eclampsia. South Afr Med J 1987; 72: 383–85.Google ScholarPubMed
152Pederson, EB, Johannesen, P, Kristensen, S et al. Calcium, parathyroid hormone and calcitonin in normal pregnancy and pre-eclampsia. Gynec Obstet Invest 1984; 18: 156–64.CrossRefGoogle Scholar
153Taufield, PA, Ales, KL, Resnick, LM, Druzin, ML, Gertner, JM, Laragh, JH., Hypocalciuria in pre-eclampsia. N Engl J Med 1987; 316: 715–18.CrossRefGoogle Scholar
154Rodriguez, MH, Masaki, DI, Mestman, J, Kumar, D, Rude, R. Calcium/creatinine ratio and microalbuminuria in the prediction of pre-eclampsia. Am J Obstet Gynecol 1989; 159: 1452–55.CrossRefGoogle Scholar
155Haller, H, Oeney, T, Hauck, U, Distler, A, Philipp, T. Increased intracellular free calcium and sensitivity to angiotensin II in platelets of pre-eclamptic women. Am J Hypertens 1989; 2: 238–43.CrossRefGoogle Scholar
156Kilby, MD, Broughton-Pipkin, F, Heptinstall, S, Symonds, EM. A comparision of platelet cytosolic free calcium concertations in both normotensive and hypertensive primigravidae. VII World congress of Hypertension in Pregnancy, 1990, Abstract no. 72.Google Scholar
157Barr, SM, Lees, KR, Butters, L, O’Donnell, A, Rubin, PC. Platelet intracellular free calcium concentrations in normotensive and hypertensive pregnancies in the human. Clin Sci 1989; 76: 67–71.CrossRefGoogle ScholarPubMed
158Zemel, MB, Zemel, PC, Berry, S et al. Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and pre-eclampsia in urban black women. N Engl J Med 1990; 323: 434–38.CrossRefGoogle ScholarPubMed
159Schleiffer, R, Berthelot, A, Gairard, A. Effects of parathyroid extract on blood pressure and arterial contraction and on Ca exchange in isolated aorta in the rat. Blood Vessels 1979; 16: 220–21.Google Scholar
160Sowers, JR, Zemel, MB, Bronston, RA et al. Erythrocyte calcium metabolism in pre-eclampsia. Am J Obstet Gynecol 1989; 161: 441–45.CrossRefGoogle Scholar
161Belizan, JM, Villar, J, Self, S, Pineda, O, Gonzalez, I, Sainz, E. The mediating role of the parathyroid gland in the effect of low calcium intake on blood pressure in the rat. Arch Latinam Nutr 1984; 34: 666–75.Google ScholarPubMed
162Tranquili, AL, Rabini, RA, Cugini, AM. et al. Calcium and sodium transport in gestational hypertension. Int J Cardiol 1989; 25: S53–55.CrossRefGoogle Scholar
163Friedman, SM. Cellular ionic perturbations in hypertension. J Hypertens 1983; 1: 109–14.CrossRefGoogle ScholarPubMed
164Lopez-Jaramillo, P, Guarner, F, Moncada, S. Effect of calcium and parathyroid hormone on prostacyclin synthesis by vascular tissue. Life Sci 1987; 40: 983–86.CrossRefGoogle ScholarPubMed
165Lopez-Jaramillo, P, Gonzalez, MC, Palmer, RMJ, Moncada, S. The crucial role of physiological Ca2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone. Br J Pharmacol 1990; 101:489–93.CrossRefGoogle ScholarPubMed
166Belizan, JM, Villar, J, Zalazar, A, Rejas, Z, Chan, D, Bryce, GF. Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant women. Am J Obstet Gynecol 1983; 146: 175–80.CrossRefGoogle ScholarPubMed
167Villar, J, Repke, J, Belizan, JM, Pareja, G. Calcium supplementation reduces blood pressure during pregnancy: results of a randomized controlled clinical trial. Obstet Gynecol 1987; 70: 317–22.Google ScholarPubMed
168Belizan, JM, Villar, J, Gonzalez, L, Campodonico, L, Bergel, E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991; 325: 1399–405.CrossRefGoogle ScholarPubMed
169Kawasaki, N, Matsui, K, Ito, M et al. Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. Am J Obstet Gynecol 1985; 153:576–82.CrossRefGoogle ScholarPubMed
170Lopez-Jaramillo, P, Narvaez, M, Weigel, RM, Yepez, R.Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynecol 1989; 96:648–65.CrossRefGoogle Scholar
171Villar, J, Repke, J.Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol 1990; 163: 1124–31.CrossRefGoogle ScholarPubMed
172Bukoski, RD, Kremer, D. Calcium-regulating hormones in hypertension: vascular actions. Am J Clin Nutr 1991; 54:2205–65.CrossRefGoogle ScholarPubMed
173Mok, LLS, Nickols, GA, Thompson, JC, Cooper, CW. Parathyroid hormone as a smooth muscle relaxant. Endocr Rev 1989; 10: 420–36.CrossRefGoogle ScholarPubMed
174Emeson, RB, Hedjran, F, Yeakley, JM, Guise, JW, Rosenfield, MA. Alternative production of calcitonin and CGRP mRNA is regulated at the calcitonin-specific splice acceptor. Nature 1989; 341: 76–80.CrossRefGoogle ScholarPubMed
175Brain, SD, Williams, TJ, Tippins, JR, Morris, HR, MacIntyre, I. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985; 313: 54–56.CrossRefGoogle ScholarPubMed
176Firth, KF, Broughton-Pipkin, F. Human ±-and ²-calcitonin gene-related peptides are vasodilators in human chorionic plate vasculature. Am J Obstet Gynecol 1989; 161: 1318–19.CrossRefGoogle Scholar
177DeBold, AJ, Borenstein, HB, Sonnenberg, H. A rapid and potent natriuretic response to the intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28:89–94.CrossRefGoogle Scholar
178Martin, DR, Pevahouse, JB, Trigg, DJ, Vesely, DL, Buerkert, JE. Three peptides from the ANF prohormone HN2-terminus are natriuretic and/or kaliuretic. Am J Physiol 1990; 258: F1401–408.Google ScholarPubMed
179Mikkelsen, AL, Schutten, G, Asping, U, Schutten, HJ. Plasma concentration of atrial natriuretic peptide in normal pregnant women and in pregnant women with pre-eclampsia. Gynecol Obstet Invest 1991; 31: 192–495.CrossRefGoogle Scholar
180Thomsen, JK, Storm, TL, Thamsborg, G, DeNully, M, Bodker, B, Skouby, S. Atrial natriuretic peptide concentrations in pre-eclampsia. Br Med J 1987; 294: 1508–10.CrossRefGoogle ScholarPubMed
181Otsuki, Y, Okamato, E, Iwata, I. et al. Changes in concentration of human atrial natriuretic peptide in normal pregnancy and toxemia. J Endocrinol 1987; 114: 325–28.CrossRefGoogle Scholar
182Rutherford, AJ, Anderson, JV, Elder, MG et al. Release of atrial natriuretic peptide during pregnancy and immediate puerperium. Lancet 1987; i: 928–29.CrossRefGoogle Scholar
183Lowe, SA, MacDonald, GJ, Brown, MA. Regulation of atrial natriuretic peptide release in pregnancy. Am J Obstet Gynecol 1991; 165: 591–95.CrossRefGoogle ScholarPubMed
184Didden, MA, Hoekstra, MP, Vollebergh, JH, Schellekens, A, de-Jong, PA. Effects of angiotensin II on atrial natriuretic peptide in pregnancy. Am J Obstet Gynecol 1991; 165: 692–95.CrossRefGoogle ScholarPubMed
185Miyamoto, S, Shimokawa, H, Sumioki, H, Touno, A, Nakano, H. Circadian rhythm of plasma atrial natriuretic peptide, aldosterone, and blood pressure during the third trimester in normal and pre-eclamptic pregnancies. Am J Obstet Gynecol 1988; 158: 393–99.CrossRefGoogle Scholar
186Merkouris, RW, Miller, FC, Catanazarite, V, Quirk, JG, Rigg, LA, Vesely, DL. The N-terminal and C-terminal portions of the atrial natriuretic factor prohormone increase during pre-eclampsia. Am J Obstet Gynecol 1991; 164: 1197–202.CrossRefGoogle Scholar
187McQueen, J, Jardine, A, Kingdom, J et al. Interactions of angiotensin II and atrial natriuretic peptide in the human fetoplacental unit. Am J Hypertens 1990; 3: 641–44.CrossRefGoogle ScholarPubMed